Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autoantibody Production in Obesity: Is There Evidence for a Link Between Obesity and Autoimmunity?
Christina Tsigalou, Natalia G. Vallianou, Μaria Dalamaga
Current Obesity Reports (2020) Vol. 9, Iss. 3, pp. 245-254
Closed Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Autoimmune pre-disease
Katja Bieber, Jennifer E. Hundt, Xinhua Yu, et al.
Autoimmunity Reviews (2022) Vol. 22, Iss. 2, pp. 103236-103236
Closed Access | Times Cited: 76
The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives
Natalia G. Vallianou, Dimitris Kounatidis, Dimitrios Tsilingiris, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6755-6755
Open Access | Times Cited: 61
Triggers for the onset and recurrence of psoriasis: a review and update
Suwen Liu, M. L. He, Jian Jiang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 30
The pleiotropic roles of leptin in metabolism, immunity, and cancer
Paola de Candia, Francesco Prattichizzo, S. Garavelli, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 5
Open Access | Times Cited: 83
Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial
Audrey M. Neyrinck, Julie Rodriguez, Zhengxiao Zhang, et al.
European Journal of Nutrition (2021) Vol. 60, Iss. 6, pp. 3159-3170
Open Access | Times Cited: 64
Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives
Μaria Dalamaga, Gerasimos Socrates Christodoulatos, Ιrene Karampela, et al.
Current Obesity Reports (2021) Vol. 10, Iss. 3, pp. 214-243
Open Access | Times Cited: 64
Obesity in late adolescence and incident type 1 diabetes in young adulthood
Inbar Zucker, Yair Zloof, Aya Bardugo, et al.
Diabetologia (2022) Vol. 65, Iss. 9, pp. 1473-1482
Open Access | Times Cited: 37
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 30
Obesity and main urologic cancers: Current systematic evidence, novel biological mechanisms, perspectives and challenges
Georgios Papavasileiou, Dimitrios Tsilingiris, Nikolaos Spyrou, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 70-98
Closed Access | Times Cited: 22
The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era
Nikolaos Spyrou, Natalia G. Vallianou, Jona Kadillari, et al.
Seminars in Cancer Biology (2021) Vol. 73, pp. 356-376
Closed Access | Times Cited: 45
SGLT-2 Inhibitors and the Inflammasome: What’s Next in the 21st Century?
Dimitris Kounatidis, Natalia G. Vallianou, Angelos Evangelopoulos, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2294-2294
Open Access | Times Cited: 20
Association of a Combination of Healthy Lifestyle Behaviors With Reduced Risk of Incident Systemic Lupus Erythematosus
May Y. Choi, Jill Hahn, Susan Malspeis, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 2, pp. 274-283
Open Access | Times Cited: 32
The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone
Changyan Zi, Die Wang, Yongxiang Gao, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 13
Association of Dietary Inflammatory Index and Thyroid Function in Patients with Hashimoto’s Thyroiditis: An Observational Cross–Sectional Multicenter Study
Sanja Klobučar Majanović, Gordana Kenđel Jovanović, Jadwiga Kryczyk‐Kozioł, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1454-1454
Open Access | Times Cited: 4
Endocrine and metabolic comorbidities in juvenile-onset systemic lupus erythematosus
Su Jin Park, Moon Bae Ahn, Dae Chul Jeong
Frontiers in Medicine (2025) Vol. 12
Open Access
Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages
Elena Y. Rykova, Vadim V. Klimontov, Elena Kazakova, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1670-1670
Open Access
Association between body roundness index and osteoarthritis/rheumatoid arthritis: a cross-sectional study
Tao Gao, Zhiyu Chen, Tao Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity
Ioannis Lempesis, Jun‐Li Liu, Μaria Dalamaga
Metabolism Open (2022) Vol. 16, pp. 100220-100220
Open Access | Times Cited: 20
Can type 1 diabetes be an unexpected complication of obesity?
Paulina Oboza, Natalia Ogarek, Magdalena Olszanecka‐Glinianowicz, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Nikolaos Spyrou, et al.
Current Obesity Reports (2023) Vol. 13, Iss. 1, pp. 1-34
Open Access | Times Cited: 11
Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management
Natalia G. Vallianou, Angelos Evangelopoulos, Dimitris Kounatidis, et al.
Current Diabetes Reviews (2021) Vol. 17, Iss. 6
Closed Access | Times Cited: 24
SGLT-2 inhibitors in obesity and its associated cardiometabolic disorders: where do we stand?
Natalia G. Vallianou, Dimitrios Tsilingiris, Dimitris Kounatidis, et al.
Polskie Archiwum Medycyny Wewnętrznej (2022)
Open Access | Times Cited: 17
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights
Hoda Y. Abdallah, Salwa Faisal, Noha Z. Tawfik, et al.
Molecular Diagnosis & Therapy (2023) Vol. 27, Iss. 3, pp. 405-423
Open Access | Times Cited: 10
Umbilical cord DNA methylation is associated with body mass index trajectories from birth to adolescence
Anat Yaskolka Meir, Wan‐Yu Huang, Tingyi Cao, et al.
EBioMedicine (2023) Vol. 91, pp. 104550-104550
Open Access | Times Cited: 10
SGLT -2 Inhibitors and the Inflammasome: What's next in the 21st century?
Dimitris Kounatidis, Natalia G. Vallianou, Angelos Evangelopoulos, et al.
(2023)
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top